Combined circulating tumor DNA and protein biomarker-based liquid biopsy for the earlier detection of pancreatic cancers
Combined circulating tumor DNA and protein biomarker-based liquid biopsy for the earlier detection of pancreatic cancers is a paper indexed in PICO Portal from OpenAlex.
How many citations does Combined circulating tumor DNA and protein biomarker-based liquid biopsy for the earlier detection of pancreatic cancers have?
Combined circulating tumor DNA and protein biomarker-based liquid biopsy for the earlier detection of pancreatic cancers has 577 citations in the OpenAlex counts PICO Portal stores.
When was Combined circulating tumor DNA and protein biomarker-based liquid biopsy for the earlier detection of pancreatic cancers published?
Combined circulating tumor DNA and protein biomarker-based liquid biopsy for the earlier detection of pancreatic cancers has 2017 year in the PICO Portal index.
What is the open-access status of Combined circulating tumor DNA and protein biomarker-based liquid biopsy for the earlier detection of pancreatic cancers?
Combined circulating tumor DNA and protein biomarker-based liquid biopsy for the earlier detection of pancreatic cancers has bronze oa status in the PICO Portal index.
What is the DOI of Combined circulating tumor DNA and protein biomarker-based liquid biopsy for the earlier detection of pancreatic cancers?
The DOI for Combined circulating tumor DNA and protein biomarker-based liquid biopsy for the earlier detection of pancreatic cancers is on the source record.
What is the PMID of Combined circulating tumor DNA and protein biomarker-based liquid biopsy for the earlier detection of pancreatic cancers?
The PMID for Combined circulating tumor DNA and protein biomarker-based liquid biopsy for the earlier detection of pancreatic cancers is on the source record.
What is the OpenAlex record for Combined circulating tumor DNA and protein biomarker-based liquid biopsy for the earlier detection of pancreatic cancers?
The OpenAlex for Combined circulating tumor DNA and protein biomarker-based liquid biopsy for the earlier detection of pancreatic cancers is on the source record.